Biofrontera (BFRI) Common Equity: 2020-2025
Historic Common Equity for Biofrontera (BFRI) over the last 4 years, with Sep 2025 value amounting to -$2.6 million.
- Biofrontera's Common Equity fell 146.67% to -$2.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.6 million, marking a year-over-year decrease of 146.67%. This contributed to the annual value of $4.4 million for FY2024, which is 7.51% down from last year.
- According to the latest figures from Q3 2025, Biofrontera's Common Equity is -$2.6 million, which was up 44.71% from -$4.7 million recorded in Q2 2025.
- In the past 5 years, Biofrontera's Common Equity ranged from a high of $23.9 million in Q4 2022 and a low of -$17.4 million during Q3 2021.
- Over the past 3 years, Biofrontera's median Common Equity value was $2.7 million (recorded in 2023), while the average stood at $3.1 million.
- As far as peak fluctuations go, Biofrontera's Common Equity skyrocketed by 432.76% in 2024, and later crashed by 146.67% in 2025.
- Over the past 5 years, Biofrontera's Common Equity (Quarterly) stood at $11.3 million in 2021, then skyrocketed by 110.60% to $23.9 million in 2022, then tumbled by 79.93% to $4.8 million in 2023, then fell by 7.51% to $4.4 million in 2024, then slumped by 146.67% to -$2.6 million in 2025.
- Its Common Equity was -$2.6 million in Q3 2025, compared to -$4.7 million in Q2 2025 and $500,000 in Q1 2025.